Omega Diagnostics Group (ODX) Share Price, News & Analysis

Company Overview

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. It markets its products approximately in 85 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 2 to 2.26
• 50-Day Range: 2.20 to 2.20
• 52-Week Range: 1.91 to 4.50
• Volume: 55,210 shs
• Average Volume: 754,609 shs
• Market Capitalization: £5.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ODX Stock Analysis - Frequently Asked Questions

How have ODX shares performed this year?

Omega Diagnostics Group's stock was trading at GBX 2.20 at the beginning of 2024. Since then, ODX stock has increased by 0.0% and is now trading at GBX 2.20.
View the best growth stocks for 2024 here.

How do I buy shares of Omega Diagnostics Group?

Shares of ODX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Omega Diagnostics Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Omega Diagnostics Group investors own include 4D pharma (DDDD), Tullow Oil (TLW), genedrive (GDR), Rolls-Royce Holdings plc (RR.L), B&M European Value Retail (BME), Coats Group (COA) and CAP-XX (CPX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: LON:ODX
• CUSIP: N/A
• CIK: N/A
• Web: www.omegadiagnostics.com
• Phone: +44-1259-763030
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 99.01
• P/E Growth: N/A
• Net Income: £-3,170,000.00
• Net Margins: -51.15%
• Pretax Margin: N/A
• Return on Equity: -29.14%
• Return on Assets: -10.53%

Debt

• Debt-to-Equity Ratio: 0.74
• Current Ratio: 4.29
• Quick Ratio: 3.31

Sales & Book Value

• Annual Sales: £7.55 million
• Price / Sales: 0.69
• Cash Flow: GBX 0.73 per share
• Price / Cash Flow: 3.00
• Book Value: GBX 4 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 237,680,000
• Free Float: N/A
• Market Cap: £5.23 million
• Optionable: Not Optionable
• Beta: 3.85